

University of Cambridge spin-out
University of Cambridge spin-out
At AdcoTx, our team is pioneering groundbreaking biotech innovations in cancer. We focus on developing advanced therapies to address global health challenges.
The Medical Research Council's Laboratory of Molecular Biology
MRC LMB, Cambridge, United Kingdom
A world leader in basic biology research
12 Nobel Prizes, 16 winners

We use the latest techniques and technologies to develop personalized treatments for patients based on their unique phenotype. This approach leads to more effective treatments that have fewer side effects.
Our team of experts works on developing immunotherapies that harness the power of the immune system to fight cancer and other diseases. We use advanced techniques to create therapies that are more effective and less toxic than traditional treatments.
Our team of experts works on developing cell and gene therapies for a variety of diseases. We use cutting-edge techniques and state-of-the-art facilities to create therapies that have the potential to cure diseases that were once thought to be incurable.
We work on developing innovative drug delivery systems that improve the efficacy and safety of drugs. Our team of experts uses advanced materials and techniques to create delivery systems that can target specific cells or tissues, and release drugs over a longer period of time.






AdcoTx
Copyright © 2026 AdcoTx - All Rights Reserved.